Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia [NA]

View source ↗

Summary

A clinical trial is investigating whether abnormal insulin action in the brain contributes to cognitive and metabolic dysfunction in schizophrenia; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Healthy | NA | Status: RECRUITING